COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
A phase IV, observational, survey-based study to measure compliance with Avonex® PS therapy in patients with Relapsing-Remitting Multiple Sclerosis, and to compare persistence on therapy 22 months after initial prescription of AVONEX® PS between patients enrolled in the current MS AllianceTM program versus patients enrolled in this program prior to October 2007.
Epistemonikos ID: d108f9acb3af9425549494d7f030bb41f441658b
First added on: May 05, 2024